JUBILANT LIFE SCIENCES LIMITED - 530019 - Announcement under Regulation 30 (LODR)-Credit Rating
Dear Sirs, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that CRISIL Limited has assigned ratings to the Company's facilities as mentioned in the attached intimation. The Company has received the letter from CRISIL Limited on April 9, 2020. This is for your kind information and record. JUBILANT LIFE SCIENCES LIMITED - 530019 - Undertaking Under Regulation 57(2) Of The SEBI (Listing Obligations And Disclosures Requirements) Regulations, 2015
Dear Sirs, We refer to our letter dated January 8, 2020 intimating that the Company has redeemed the outstanding Non-Convertible Debentures alongwith accrued interest thereon on January 7, 2020. Pursuant to the provisions of Regulation 57(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company has provided all the documents and intimations required to be submitted to the Debenture Trustee i.e. Vistra ITCL (India) Limited during the Financial Year 2019-20 in terms of the Debenture Trust Deeds and the SEBI (Issue and Listing of Debt Securities) Regulations, 2008. This is for your information and records.
Management Call: Jubilant Life Sciences on Covid impact
Conference Call with Management of Jubilant Life Sciences and Analysts on covid impact. Listen in on the full transcript here. Key Remarks - The world is in an unprecedented situation due to Covid-19 - The Indian government has responded strongly, but we are already seeing economic impact particularly low income households and migrants - The good news is that we are currently seeing strong performance, thanks to diversity in geos, and most of our businesses are under essential business category - We have ensured adequate stock right now of raw material. Diligently monitoring our supply situation in US and Canada. We have largely been able to keep our plants running - The Nanjangud plant saw closure for a few days after two workers tested positive for covid. JUBILANT LIFE SCIENCES LIMITED - 530019 - Schedule Of Investor Conference Call For Jubilant Life Sciences Limited - Update On Company'S Position With Respect To COVID-19 Pandemic
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company is organising a Conference Call on April 1, 2020 at 5.00 p.m. to update the Company's position with respect to COVID-19 pandemic. Details of the Conference Call are attached. This is for information and record. Jubilant Life Nanjangud plant closed as some staff found Covid-19 positive
Drug firm Jubilant Life Sciences on Tuesday said its Nanjangud plant in Karnataka has been shut until April 10 and all the employees are under self-q JUBILANT LIFE SCIENCES LIMITED - 530019 - Jubilant Receives EIR From USFDA For Its Solid Dosage Facility At Salisbury, Maryland USA
Dear Sirs, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose a communication pertaining to USFDA inspection. We request you to take the same on record. JUBILANT LIFE SCIENCES LIMITED - 530019 - Jubilant Life Sciences Ltd reply to clarification sought by the exchange
The Exchange had sought clarification from Jubilant Life Sciences Ltd with respect to news article appearing on zeebiz.com March 30, 2020 titled "Jubilant Life Sciences hit by coronavirus; Nanjangud plant API production shut".Jubilant Life Sciences Ltd response is enclosed. JUBILANT LIFE SCIENCES LIMITED - 530019 - Clarification sought from Jubilant Life Sciences Ltd
The Exchange has sought clarification from Jubilant Life Sciences Ltd with respect to news article appearing on zeebiz.com March 30, 2020 titled "Jubilant Life Sciences hit by coronavirus; Nanjangud plant API production shut".The reply is awaited. Corporates ramp up manufacturing facilities to counter coronavirus spread
Our BureauCorporates are ramping up manufacturing facilities to counter the spread of the coronavirus. Jubilant Life Sciences' research and developmen JUBILANT LIFE SCIENCES LIMITED - 530019 - Closure of Trading Window
Pursuant to the Company's Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company will be closed for 'Designated Persons' from Wednesday, March 25, 2020 and the same shall remain closed till 48 hours after announcement of the financial results for the quarter and year ending March 31, 2020 to the Stock Exchanges. Accordingly, the Designated Persons have been intimated not to trade in the securities of the Company during the aforesaid period of closure of Trading Window. This is for your information and records.